“…For instance, in the serum of septic patients with highly oxidative profile (whose prognosis is death), it is observed 30-fold increase in serum HSP70 (eHSP70) compared with control subjects (Gelain et al, 2011), whereas the amount of intracellular HSP70 expressed in the cells of such subjects is, as a rule, lower that that expected. Corroborating this proposition, the expression of HSP70 by pancreatic islets from diabetes-prone BB rats has been found to be lower than that in diabeticresistant LEW rats of same age and, in the diabetes-prone BB rats, HSP70 expression has shown to be much lower in young as compared to adult animals (Wachlin et al, 2002). Since intracellular HSP70 functions as a potent anti-inflammatory cellular tool due to the impairment over NF-B downstream pathways, a deficient HSP70 may threaten -cell survival (see Hooper & Hooper, 2005, for review).…”